Association of pharmacotherapy with the second hip fracture incidence in women: A retrospective analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Shinichi NakatohKenji FujimoriShigeyuki IshiiJunko TamakiNobukazu OkimotoSumito OgawaMasayuki IkiPublished in: Geriatrics & gerontology international (2022)
Differences in patient background characteristics and the rate of patients with MPR ≥80% might underlie the observed differences in the crude incidence of second hip fracture among the medication groups. Geriatr Gerontol Int 2022; 22: 930-937.
Keyphrases
- hip fracture
- health insurance
- risk factors
- affordable care act
- healthcare
- public health
- adverse drug
- polycystic ovary syndrome
- mental health
- case report
- quality improvement
- smoking cessation
- health information
- emergency department
- type diabetes
- pregnancy outcomes
- pregnant women
- skeletal muscle
- electronic health record
- climate change
- breast cancer risk